Stock Ratings | Bernstein raised its price target for SanDisk (SNDK) from $1,700 to $3,000; Citizens raised its price target for DBV Technologies (DBVT) to $55, representing a potential upside of 235.37%.
DBV Technologies SA Sponsored ADR DBVT | 0.00 | |
BioCryst Pharmaceuticals, Inc. BCRX | 0.00 | |
Viridian Therapeutics, Inc. VRDN | 0.00 | |
Sandisk Corporation SNDK | 0.00 | |
Unicycive Therapeutics UNCY | 0.00 |
The ratings of major US investment banks are used to track the latest valuations and target prices on Wall Street daily, and to explore potential equity investment opportunities.
Risk warning:
Investing in small-cap stocks can be risky. Be prepared for potential challenges related to liquidity, high volatility, limited information, and financial instability. Always diversify your investments.
Today's key assessments and concerns
Citizens: Maintaining DBV Technologies' ( DBV Technologies SA Sponsored ADR(DBVT.US) ) rating at "Outperform Market", while raising the price target from $47 to $55.
Cantor Fitzgerald: Maintaining an "overweight" rating on BioCryst Pharmaceuticals ( BioCryst Pharmaceuticals, Inc.(BCRX.US) ), while raising the price target from $27 to $29.
Wedbush: Maintaining Viridian Viridian Therapeutics, Inc.(VRDN.US) ' rating at "Outperform Market", while raising the price target from $32 to $43.
Bernstein: Maintaining its "outperform" rating for SanDisk ( Sandisk Corporation(SNDK.US) ), while raising its price target from $1,700 to $3,000.
HC Wainwright & Co.: Maintaining a "buy" rating on Unicycive Therapeutics ( Unicycive Therapeutics(UNCY.US) ), while lowering the price target from $22 to $15.
| The symbol | Classification | Target price | Current price | Percentage of potential increase/decrease | (Classification) Agency |
| DBV Technologies SA Sponsored ADR(DBVT.US) | to lift | $55.0 | $16.4 | 235.37% | Citizens |
| BioCryst Pharmaceuticals, Inc.(BCRX.US) | to lift | $29.0 | $10.0 | 190.0% | Cantor Fitzgerald |
| Viridian Therapeutics, Inc.(VRDN.US) | to lift | $43.0 | $18.37 | 134.08% | Wedbush |
| Taysha Gene Therapies, Inc.(TSHA.US) | to lift | $15.0 | $6.81 | 120.26% | Baird |
| Viridian Therapeutics, Inc.(VRDN.US) | to lift | $38.0 | $18.37 | 106.86% | Truist Securities |
| Alteriry Therapeutics Ltd Sponsored ADR(ATHE.US) | Initial classification | $16.0 | $5.37 | 197.95% | Jones Trading |
| Unicycive Therapeutics(UNCY.US) | cut | $15.0 | $4.69 | 219.83% | HC Wainwright & Co. |
| Strategy(MSTR.US) | cut | $260.0 | $86.93 | 199.09% | TD Cowen |
| Strategy(MSTR.US) | cut | $250.0 | $86.93 | 187.59% | BTIG |
| Concentrix Corporation(CNXC.US) | cut | $45.0 | $22,405 | 100.85% | Canaccord Genuity |
comments:
Target price unit and current price: US Dollar;
Current price: As of the latest closing price of US stocks;
Potential percentage increase/potential decrease = (Agency target price - current price) / current price 100% (Current price = Last closing price up to the time of the count)
Lifting
Susquehanna: Maintaining a "positive" rating on Applied Materials ( Applied Materials, Inc.(AMAT.US) stock, while raising the price target from $575 to $900.
Wells Fargo: Maintaining Advanced Micro Devices, Inc.(AMD.US) rating at "overweight", while raising the price target from $505 to $615.
Deutsche Bank: Maintaining a "buy" rating on Robinhood Markets ( Robinhood(HOOD.US) ), while raising the price target from $105 to $113.
Susquehanna: Maintaining a "positive" rating on Lam Lam Research Corporation(LRCX.US) ) stock, while raising the price target from $385 to $475.
BTIG: Maintaining a "buy" rating on Palo Alto Networks ( Palo Alto Networks, Inc.(PANW.US) ), while raising the price target from $333 to $380.
B of A Securities: Maintaining a "buy" rating on Rocket Rocket Lab(RKLB.US) stock, while raising the price target from $105 to $115.
Bernstein: Maintaining its "outperform" rating for SanDisk ( Sandisk Corporation(SNDK.US) ), while raising its price target from $1,700 to $3,000.
Morgan Stanley: Maintaining an "overweight" rating on UnitedHealth ( UnitedHealth Group Incorporated(UNH.US) ), while raising the price target from $453 to $468.
Morgan Stanley: Maintaining an "overweight" rating for Google-A ( Alphabet Inc. Class A(GOOGL.US) ) stock, while raising the price target from $375 to $415.
First Coverage
Piper Sandler: Initial rating for Capital One Financial Capital One Financial Corp(COF.US) ) stock at "overweight", with a price target of $254.
Piper Sandler: Initial rating for Mastercard Mastercard(MA.US) ) stock at "overweight", with a price target of $597.
Benchmark: A preliminary rating of "buy" for Rocket Companies Rocket(RKT.US) ) stock, with a target price of $21.
reduction
RBC Capital: Maintaining its "Outperform Market" rating for AeroVironment ( AeroVironment, Inc.(AVAV.US) ), while lowering its price target from $250 to $210.
TD Cowen: Maintaining Strategy ( Strategy(MSTR.US) ) rating at "Buy", while lowering the price target from $400 to $260.
TD Securities: Downgraded Bio-Techne ( Bio-Techne Corporation(TECH.US) ) stock to "Hold", while raising its price target from $65 to $73.
TD Cowen: Maintaining a "buy" rating on Zoetis Zoetis, Inc. Class A(ZTS.US) ) stock, while lowering the price target from $150 to $104.
Editor's Note: This content was created by Saham's AI-powered SaaS tool and reviewed by our editorial team.
Risk Warning: Investing involves risk. Securities may rise, fall, or become worthless. Investing does not guarantee profits and may result in losses. Past performance is not necessarily indicative of future results. Before making any investment decision, investors should assess their financial situation, investment objectives, experience, risk tolerance, and understand the nature of the investment products and their associated risks. For more details on the nature and risks of each investment product, please read the relevant offering documents carefully. If you have any questions, it is advisable to seek independent professional advice.